Novartis AG

Switzerland

Novartis AG

Lichtstrasse 35 Basel, 4056 Switzerland

p> Joseph Jimenez - Chief Executive Officer of Novartis,

Juergen Brokatzky-Geiger, Ph.D. - Head of Human Resources,

Kevin Buehler- Division Head, Alcon,

Felix Ehrat, Ph.D.- General Counsel,

David Epstein- Division Head, Novartis Pharmaceuticals,

Mark C. Fishman, M.D.- President of the Novartis Institutes for BioMedical Research (NIBR),

Jeff George- Division Head, Sandoz,

George Gunn, MRCVS- Division Head Novartis Animal Health,Head, Novartis Corporate Responsibility,

Brian McNamara- Division Head, Novartis OTC,

Andrin Oswald, M.D.- Division Head, Novartis Vaccines and Diagnostics,

Jon Symonds- Chief Financial Officer of Novartis AG.

Cardiology, Neurology, Endocrinology, Ophthalmology, Pulmonology, Therapy

Production

Cerebral circulation disorder, Pyelonephritis, Bacterial pneumonia, Glaucoma, Diabetes, Atherosclerosis

NVS

Ulrich Lehner, Ph.D., Chairman a.i.
Enrico Vanni, Ph.D., Vice Chairman
Dimitri Azar, M.D., MBA
William Brody, M.D., Ph.D.
Srikant Datar, Ph.D.
Ann Fudge
Pierre Landolt, Ph.D.
Andreas von Planta, Ph.D.
Dr. Ing. Wendelin Wiedeking
Rolf M. Zinkernagel, M.D.
Charles L. Sawyers, M.D.
Verena A. Briner, M.D.
William T. Winters

245.9800

Cell Technologies, Services, Technologies, Pharmaceuticals, Chemistry